NEPHROS, INC. Deferred Tax Assets, Operating Loss Carryforwards
NEPHROS, INC. (NEPH) had Deferred Tax Assets, Operating Loss Carryforwards of $15.08 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.08M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.63M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.70M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.67M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $15.08M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $15.63M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $16.70M 10-K · filed 2025-03-24 | |
| 2022-12-31 | $17.67M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $18.47M 10-K · filed 2023-03-23 | |
| 2020-12-31 | $17.92M 10-K · filed 2022-03-03 | |
| 2019-12-31 | $18.06M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $18.67M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $17.91M 10-K · filed 2019-03-12 | |
| 2016-12-31 | $29.86M 10-K · filed 2018-02-26 | $29.86M 10-K · filed 2017-03-20 |
| 2015-12-31 | $29.09M 10-K · filed 2017-03-20 | |
| 2014-12-31 | $27.94M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $27.03M 10-K · filed 2015-04-15 | |
| 2012-12-31 | $25.72M 10-K · filed 2014-03-28 | |
| 2011-12-31 | $24.71M 10-K · filed 2013-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |